• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

一种眼睑加热装置与传统热敷疗法的比较。

A comparison of an eyelid-warming device to traditional compress therapy.

作者信息

Pult Heiko, Riede-Pult Britta H, Purslow Christine

机构信息

Dr. Heiko Pult-Optometry & Vision Research, Weinheim, Germany.

出版信息

Optom Vis Sci. 2012 Jul;89(7):E1035-41. doi: 10.1097/OPX.0b013e31825c3479.

DOI:10.1097/OPX.0b013e31825c3479
PMID:22729167
Abstract

PURPOSE

To assess the warming and humidifying effect and ocular safety of the Blephasteam® eyelid-warming device vs. warm and moist compresses in healthy volunteers.

METHODS

Twenty subjects (8 females, 12 males; mean age 39.2 years) were included in the study. Temperature and relative humidity were measured over a period of 10 min at the lower eyelid margin of one randomly selected eye during application of the Blephasteam device and, 1 h later, during application of warm compresses (in a randomized order). Ocular signs and visual acuity were assessed before and after each application.

RESULTS

The mean duration of warming (temperature ≥38°C) was significantly longer with Blephasteam than with compresses (7.5 vs. 1.0 min; p < 0.01). There was no significant difference between treatments in the duration of 100% relative humidity. Compared with pretreatment values, visual acuity significantly improved after Blephasteam treatment (p < 0.05) but significantly decreased after treatment with compresses (p < 0.05). Limbal redness, eyelid redness, and corneal staining scores all improved significantly after Blephasteam treatment (p < 0.05 for all). Ocular signs did not change after compress treatment except conjunctival redness, which was significantly increased (p = 0.01 vs. pretreatment).

CONCLUSIONS

The Blephasteam eyelid-warming device appeared to provide more effective warming than warm and moist compresses in a group of healthy volunteers. Visual acuity, limbal redness, and eyelid redness were improved after Blephasteam use but not after treatment with compresses.

摘要

目的

评估Blephasteam®眼睑加热装置与温热湿敷对健康志愿者的温热加湿效果及眼部安全性。

方法

本研究纳入20名受试者(8名女性,12名男性;平均年龄39.2岁)。在随机选择的一只眼睛的下眼睑边缘,分别在使用Blephasteam装置期间及1小时后使用温热湿敷时(顺序随机),测量10分钟内的温度和相对湿度。每次使用前后评估眼部体征和视力。

结果

Blephasteam的平均升温持续时间(温度≥38°C)显著长于湿敷(7.5分钟对1.0分钟;p<0.01)。两种治疗方法在100%相对湿度持续时间上无显著差异。与治疗前值相比,Blephasteam治疗后视力显著提高(p<0.05),而湿敷治疗后视力显著下降(p<0.05)。Blephasteam治疗后角膜缘充血、眼睑充血和角膜染色评分均显著改善(均p<0.05)。湿敷治疗后除结膜充血显著增加外(与治疗前相比p = 0.01),眼部体征无变化。

结论

在一组健康志愿者中,Blephasteam眼睑加热装置似乎比温热湿敷提供更有效的升温。使用Blephasteam后视力、角膜缘充血和眼睑充血得到改善,但湿敷治疗后未改善。

相似文献

1
A comparison of an eyelid-warming device to traditional compress therapy.一种眼睑加热装置与传统热敷疗法的比较。
Optom Vis Sci. 2012 Jul;89(7):E1035-41. doi: 10.1097/OPX.0b013e31825c3479.
2
Evaluation of the ocular tolerance of a novel eyelid-warming device used for meibomian gland dysfunction.评估一种新型眼睑加热装置治疗睑板腺功能障碍的眼部耐受性。
Cont Lens Anterior Eye. 2013 Oct;36(5):226-31. doi: 10.1016/j.clae.2013.02.009. Epub 2013 Apr 6.
3
Efficacy of a new warm moist air device on tear functions of patients with simple meibomian gland dysfunction.一种新型温热湿化空气装置对单纯睑板腺功能障碍患者泪液功能的疗效
Cornea. 2006 Jul;25(6):644-50. doi: 10.1097/01.ico.0000208822.70732.25.
4
Evaluation of a novel eyelid-warming device in meibomian gland dysfunction unresponsive to traditional warm compress treatment: an in vivo confocal study.新型眼睑加热装置治疗对传统热敷治疗无反应的睑板腺功能障碍的体内共聚焦研究
Int Ophthalmol. 2015 Jun;35(3):319-23. doi: 10.1007/s10792-014-9947-3. Epub 2014 Apr 22.
5
Evaluation of an eyelid warming device (Blephasteam) for the management of ocular surface diseases in France: the ESPOIR study.法国一项关于眼睑温热装置(Blephasteam)用于治疗眼表疾病的评估:ESPOIR研究。
J Fr Ophtalmol. 2014 Dec;37(10):763-72. doi: 10.1016/j.jfo.2014.06.004. Epub 2014 Oct 1.
6
Increase in tear film lipid layer thickness following treatment with warm compresses in patients with meibomian gland dysfunction.睑板腺功能障碍患者热敷治疗后泪膜脂质层厚度增加。
Eye Contact Lens. 2003 Apr;29(2):96-9. doi: 10.1097/01.ICL.0000060998.20142.8D.
7
Infrared thermography: different options of thermal eyelid warming.红外热成像:眼睑热疗的不同选择。
Graefes Arch Clin Exp Ophthalmol. 2020 Jul;258(7):1515-1522. doi: 10.1007/s00417-020-04673-0. Epub 2020 Apr 11.
8
Ex vivo heat retention of different eyelid warming masks.不同眼睑热敷面罩的体外热保留情况。
Cont Lens Anterior Eye. 2015 Jun;38(3):152-6. doi: 10.1016/j.clae.2015.01.005. Epub 2015 Feb 27.
9
All Warm Compresses Are Not Equally Efficacious.并非所有热敷都具有同等疗效。
Optom Vis Sci. 2015 Sep;92(9):e327-33. doi: 10.1097/OPX.0000000000000675.
10
Warm compress induced visual degradation and Fischer-Schweitzer polygonal reflex.热敷导致视力下降及费舍尔-施韦策尔多边形反射。
Optom Vis Sci. 2007 Jul;84(7):580-7. doi: 10.1097/OPX.0b013e3180dc99d5.

引用本文的文献

1
Efficacy and safety of the disposable eyelid warming masks in the treatment of dry eye disease due to Meibomian gland dysfunction.一次性眼睑加温眼罩治疗睑板腺功能障碍相关性干眼的疗效和安全性。
BMC Ophthalmol. 2024 Aug 26;24(1):376. doi: 10.1186/s12886-024-03642-z.
2
Treatment of Dry Eye Disease (DED) in Asia: Strategies for Short Tear Film Breakup Time-Type DED.亚洲干眼症(DED)的治疗:短泪膜破裂时间型干眼症的治疗策略
Pharmaceutics. 2023 Nov 5;15(11):2591. doi: 10.3390/pharmaceutics15112591.
3
Eyelid Warming Devices: Safety, Efficacy, and Place in Therapy.
眼睑温热装置:安全性、有效性及在治疗中的地位。
Clin Optom (Auckl). 2022 Aug 5;14:133-147. doi: 10.2147/OPTO.S350186. eCollection 2022.
4
TheraPearl Eye Mask and Blephasteam for the treatment of meibomian gland dysfunction: a randomized, comparative clinical trial.TheraPearl 眼贴眼罩和 Blephasteam 治疗睑板腺功能障碍:一项随机、对照的临床试验。
Sci Rep. 2021 Nov 17;11(1):22386. doi: 10.1038/s41598-021-01899-8.
5
Efficacy and safety of a vectored thermal pulsation system (Lipiflow®) in the treatment of meibomian gland dysfunction: a systematic review and meta-analysis.经向量热脉动系统(Lipiflow®)治疗睑板腺功能障碍的疗效和安全性:系统评价和荟萃分析。
Graefes Arch Clin Exp Ophthalmol. 2022 Jan;260(1):25-39. doi: 10.1007/s00417-021-05363-1. Epub 2021 Aug 10.
6
Formulation Considerations for the Management of Dry Eye Disease.干眼症管理的制剂考量
Pharmaceutics. 2021 Feb 3;13(2):207. doi: 10.3390/pharmaceutics13020207.
7
Therapeutic Instruments Targeting Meibomian Gland Dysfunction.针对睑板腺功能障碍的治疗仪器
Ophthalmol Ther. 2020 Dec;9(4):797-807. doi: 10.1007/s40123-020-00304-3. Epub 2020 Sep 24.
8
Infrared thermography: different options of thermal eyelid warming.红外热成像:眼睑热疗的不同选择。
Graefes Arch Clin Exp Ophthalmol. 2020 Jul;258(7):1515-1522. doi: 10.1007/s00417-020-04673-0. Epub 2020 Apr 11.
9
Efficacy and Safety of Wet Wipes Containing Hy-Ter Solution Compared with Standard Care for Bilateral Posterior Blepharitis: A Preliminary Randomized Controlled Study.含Hy-Ter溶液的湿纸巾与标准护理治疗双侧后部睑缘炎的疗效和安全性:一项初步随机对照研究。
Ophthalmol Ther. 2019 Jun;8(2):313-321. doi: 10.1007/s40123-019-0182-x. Epub 2019 Mar 30.
10
An Eyelid Warming Device for the Management of Meibomian Gland Dysfunction.一种用于治疗睑板腺功能障碍的眼睑加热装置。
J Optom. 2019 Apr-Jun;12(2):120-130. doi: 10.1016/j.optom.2018.07.002. Epub 2018 Oct 16.